Betts Dean H, Bain Nathan T, Madan Pavneesh
Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada ; Children's Health Research Institute, Lawson Health Research Institute, London, Ontario, Canada.
Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
PLoS One. 2014 Jan 24;9(1):e86978. doi: 10.1371/journal.pone.0086978. eCollection 2014.
The in vitro production of mammalian embryos suffers from high frequencies of developmental failure due to excessive levels of permanent embryo arrest and apoptosis caused by oxidative stress. The p66Shc stress adaptor protein controls oxidative stress response of somatic cells by regulating intracellular ROS levels through multiple pathways, including mitochondrial ROS generation and the repression of antioxidant gene expression. We have previously demonstrated a strong relationship with elevated p66Shc levels, reduced antioxidant levels and greater intracellular ROS generation with the high incidence of permanent cell cycle arrest of 2-4 cell embryos cultured under high oxygen tensions or after oxidant treatment. The main objective of this study was to establish a functional role for p66Shc in regulating the oxidative stress response during early embryo development. Using RNA interference in bovine zygotes we show that p66Shc knockdown embryos exhibited increased MnSOD levels, reduced intracellular ROS and DNA damage that resulted in a greater propensity for development to the blastocyst stage. P66Shc knockdown embryos were stress resistant exhibiting significantly reduced intracellular ROS levels, DNA damage, permanent 2-4 cell embryo arrest and diminished apoptosis frequencies after oxidant treatment. The results of this study demonstrate that p66Shc controls the oxidative stress response in early mammalian embryos. Small molecule inhibition of p66Shc may be a viable clinical therapy to increase the developmental potential of in vitro produced mammalian embryos.
由于氧化应激导致的永久性胚胎停滞和细胞凋亡水平过高,哺乳动物胚胎的体外生产存在着较高频率的发育失败问题。p66Shc应激衔接蛋白通过多种途径调节细胞内活性氧(ROS)水平,包括线粒体ROS的产生和抗氧化基因表达的抑制,从而控制体细胞的氧化应激反应。我们之前已经证明,在高氧张力下培养或经过氧化剂处理后,2-4细胞胚胎永久性细胞周期停滞的发生率较高,这与p66Shc水平升高、抗氧化剂水平降低以及细胞内ROS产生增加密切相关。本研究的主要目的是确定p66Shc在早期胚胎发育过程中调节氧化应激反应的功能作用。通过对牛受精卵进行RNA干扰,我们发现敲低p66Shc的胚胎表现出锰超氧化物歧化酶(MnSOD)水平升高、细胞内ROS和DNA损伤减少,从而使其发育到囊胚阶段的倾向更大。敲低p66Shc的胚胎具有应激抗性,在氧化剂处理后,其细胞内ROS水平、DNA损伤、永久性2-4细胞胚胎停滞以及细胞凋亡频率均显著降低。本研究结果表明,p66Shc控制早期哺乳动物胚胎的氧化应激反应。小分子抑制p66Shc可能是一种可行的临床治疗方法,以提高体外生产的哺乳动物胚胎的发育潜力。